This smallcap pharmaceutical stock has zoomed 62% thus far in December

Medicamen Biotech hit a new high of Rs 948.95, having rallied 13 per cent on the BSE in Thursday's intra-day deal.

Shares of Medicamen Biotech (MBL) hit a new high of Rs 948.95 after they rallied 13 per cent on the BSE in Thursday's intra-day deal. Thus far in the month of December, the stock of the smallcap pharmaceutical company has zoomed 62 per cent, ahead of the launch of domestic marketing of its Oncology products. In comparison, the S&P BSE Sensex was up 0.32 per cent so far in the current month. At 02:05 pm, MBL was up 11 per cent at Rs 928.55, as against 0.65 per cent rise in the benchmark index.

The company has nearly two-decade-long